Guatemala vs Portugal: Access to anti-retroviral drugs, male
Guatemala
82.0%
in 2024
Portugal
82.0%
in 2017
Guatemala rank
42nd
Portugal rank
42nd
Access to anti-retroviral drugs, male over time
- Guatemala
- Portugal
How they compare
Guatemala currently reports 82.0% against 82.0% in Portugal, a difference of 0.0%.
The two have swapped places 2 times across 18 shared years of data; in 2000 it was Portugal ahead.
Guatemala ranks 42nd and Portugal ranks 42nd of 141 countries.
Portugal has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Guatemala | Portugal | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 19.8% | 30.8% | 11.0% | Portugal |
| 2010s | 54.0% | 63.9% | 9.9% | Portugal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Guatemala or Portugal?
- Guatemala, at 82.0% against 82.0% in Portugal as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Guatemala and Portugal?
- 0.0%, with Guatemala ahead.
- How many years of comparable data are there for Guatemala and Portugal?
- 18 years are reported by both, from 2000 to 2017.
- How do Guatemala and Portugal rank globally for access to anti-retroviral drugs, male?
- Guatemala ranks 42nd and Portugal ranks 42nd of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.